Financing

Medicover’s financing strategy is designed to ensure long-term financial stability, strong liquidity, and flexibility to support continued growth. Through a diversified mix of funding instruments, varying maturities, and access to committed credit facilities, the group mitigates refinancing and liquidity risk while securing the future and future investments.

Revolving credit facility

Medicover signed in May 2026 a new EUR 450 million syndicated revolving credit facility agreement. The facility has a maturity of three years with two one-year extension options subject to lenders‘ approval. The facility replaces the EUR 300 million revolving credit facility dated June 2022. 

Borrower:Medicover Holding S.A.
Guarantor:Medicover AB (publ)
Size:EUR 450,000,000
Tenors:3 years with two 1-year extension
Joint arrangers:•    Nordea acted as Coordinating Bookrunner and Mandated Lead Arranger, Documentation Agent and Facility Agent 
•    Erste Bank Polska, ING, Landesbank Hessen-Thüringen, Raiffeisen and SEB acted as Bookrunners and Mandated Lead Arranger
•    Bank Pekao, Oldenburgische Landesbank and UniCredit acted as Mandated Lead Arranger

Social Finance Framework

Medicover has updated its Social Finance Framework in line with the ICMA Social Bond Principles 2023 as well as the LMA Social Loan Principles 2025. To secure alignment with the Social Bond Principles and market practice Medicover has engaged DNV GL to act as an external reviewer of the Social Finance Framework and to provide a Second Party Opinion.

Social Finance Framework 2025 (PDF)

DNV Second Party Opinion 2025 (PDF)

Social Finance Framework 2021 (PDF)

DNV Eligibility Assessment Social Finance Framework 2021 (PDF)

Social Finance Investor Report 2022 (PDF)

Social Finance Investor Report 2023 (PDF)

Social Finance Investor Report 2024 (PDF)

Social Finance Investor Report 2025 (PDF)

 

Social Finance Schuldschein

Medicover has  an outstanding volume of EUR 372 million Social Schuldschein debt.

Borrower:Medicover Holding S.A.
Guarantor:Medicover AB (publ)
Size:EUR 372,000,000
Tenors:3.5, 4, 5.5, 7.5 and 10 years fixed and float
Joint arrangers:Landesbank Hessen-Thüringen Girozentrale (Helaba), ING Bank, a branch of ING-DiBa AG, and Skandinaviska Enskilda Banken AB (publ) (SEB), Frankfurt Branch, and SEB as sole social structuring advisor

Social commercial paper

Medicover AB (publ) has established a Swedish Social sustainable commercial paper programme with a total frame of MSEK 3,000. The financing will mainly be used for short-term capital needs and are listed on Nasdaq Stockholm as a non-equity instrument. 

Issuer:Medicover AB
Programme size:SEK 3,000,000,000
Currency:SEK and EUR
Duration:1-12 months
Issuing Agent:Nordea Bank Abp (IPA) and Skandinaviska Enskilda Banken AB

 

Contact:
Valur Sveinbjörnsson, Corporate Treasury Director
[email protected]